Patents protect new inventions, in all fields of technology.
Mewburn Ellis LLP has patent specialists in all technical disciplines and a wealth of experience in drafting and prosecuting patent applications and advising on their enforcement. We can also advise on the potential impact of other people’s patents on your business.
Latest Patent NewsSee all news >
11 February 2015
We wish to congratulate our client MerLion Pharmaceuticals (MerLion) on achieving FDA approval of their drug finafloxacin otic suspension. Finafloxacin is an antibiotic that has been developed to treat ear infections, in particular acute otitis externa, commonly known as “swimmer’s ear”.
Mewburn Ellis partners Jeremy Webster, Richard Clegg and Sean Jauss have been assisting MerLion for the last 7 years with their patent portfolio, including supporting their successful licensing negotiations with a major North American partner on this particular drug.
MerLion’s success with finafloxacin is a notable milestone in the development of Singapore’s biomedical sciences industry, being the first novel drug from a Singaporean company to achieve FDA approval.Click here for more information
23 January 2015
Under an agreement between the EPO and the Moroccan Government, Morocco will be the first of the EPO’s “validation” countries. From 1 March 2015, if “validation” in Morocco is chosen for a European Patent application, the European Patent will have effect in Morocco as if it were a Moroccan national patent.
Morocco will be the first African country to have a direct link of this type with the EPO. It is rumoured that a similar agreement with Tunisia will be made as well.Click here for more information
Our peopleView patents specialists >
UP COMING EVENTS
Focus on Innovation
Innovation: the creation of new and exciting products, services and solutions. A key part of every successful business.